EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RET enhancer haplotype-dependent remodeling of the human fetal gut development program

Sumantra Chatterjee iD, Lauren E Fries, Or Yaacov iD, Nan Hu, Hanna E Berk-Rauch, Aravinda Chakravarti

PLOS Genetics · 10.11.2023 · 19 (11) · e1011030

DOI: 10.1371/journal.pgen.1011030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 10.11.2023. Verfasst von Sumantra Chatterjee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, United States of America. Hauptthemen laut MEDLINE: Enhancer Elements, Genetic, Proto-Oncogene Proteins c-ret, Gastrointestinal Tract. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hirschsprung disease (HSCR) is associated with deficiency of the receptor tyrosine kinase RET, resulting in loss of cells of the enteric nervous system (ENS) during fetal gut development. The major contribution to HSCR risk is from common sequence variants in RET enhancers with additional risk from rare coding variants in many genes. Here, we demonstrate that these RET enhancer variants specifically alter the human fetal gut development program through significant decreases in gene expression of RET , members of the RET-EDNRB gene regulatory network (GRN), other HSCR genes, with an altered transcriptome of 2,382 differentially expressed genes across diverse neuronal and mesenchymal functions. A parsimonious hypothesis for these results is that beyond RET’s direct effect on its GRN, it also has a major role in enteric neural crest-derived cell (ENCDC) precursor proliferation, its deficiency reducing ENCDCs with relative expansion of non-ENCDC cells. Thus, genes reducing RET proliferative activity can potentially cause HSCR. One such class is the 23 RET -dependent transcription factors enriched in early gut development. We show that their knockdown in human neuroblastoma SK-N-SH cells reduces RET and/or EDNRB gene expression, expanding the RET-EDNRB GRN. The human embryos we studied had major remodeling of the gut transcriptome but were unlikely to have had HSCR: thus, genetic or epigenetic changes in addition to those in RET are required for aganglionosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enhancer Elements, GeneticProto-Oncogene Proteins c-retGastrointestinal TractHaplotypesHumansNeuroblastomaCell Line, TumorHirschsprung DiseaseFetusNeural CrestEnteric Nervous SystemSingle-Cell Gene Expression AnalysisGene Expression Regulation, Developmental

Substanzen

RET protein, humanProto-Oncogene Proteins c-ret

Autor:innen und Institutionen

  • Center for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, United States of America.
  • Department of Neuroscience and Physiology, New York University Grossman School of Medicine, New York, United States of America.

ORCID-Profile: Sumantra Chatterjee, Or Yaacov

Förderung

  • Wellcome Trust
  • Medical Research Council
  • NICHD NIH HHS
  • School of Medicine, New York University
  • Human Developmental Biology Resource

Zitieren

APA

Chatterjee, S., Fries, L. E., Yaacov, O., Hu, N., Berk-Rauch, H. E., & Chakravarti, A. (2023). RET enhancer haplotype-dependent remodeling of the human fetal gut development program. PLOS Genetics, 19(11), e1011030. https://doi.org/10.1371/journal.pgen.1011030

Vancouver

Chatterjee S, Fries LE, Yaacov O, Hu N, Berk-Rauch HE, Chakravarti A. RET enhancer haplotype-dependent remodeling of the human fetal gut development program. PLOS Genetics. 2023;19(11):e1011030. doi:10.1371/journal.pgen.1011030

BibTeX
@article{Chatterjee2023,
  author = {Chatterjee, Sumantra and Fries, Lauren E and Yaacov, Or and Hu, Nan and Berk-Rauch, Hanna E and Chakravarti, Aravinda},
  title = {RET enhancer haplotype-dependent remodeling of the human fetal gut development program},
  journal = {PLOS Genetics},
  year = {2023},
  volume = {19},
  number = {11},
  pages = {e1011030},
  doi = {10.1371/journal.pgen.1011030}
}
Kostenlos starten →